| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.52B | 54.23B | 46.73B | 48.14B | 43.81B | 39.29B |
| Gross Profit | 21.62B | 20.29B | 16.27B | 17.38B | 16.59B | 14.77B |
| EBITDA | 16.82B | 15.57B | 12.25B | 13.55B | 13.04B | 11.66B |
| Net Income | 8.75B | 8.05B | 6.33B | 7.35B | 6.91B | 5.46B |
Balance Sheet | ||||||
| Total Assets | 80.15B | 82.78B | 77.94B | 74.90B | 70.07B | 64.65B |
| Cash, Cash Equivalents and Short-Term Investments | 15.68B | 17.98B | 20.91B | 20.91B | 20.11B | 19.23B |
| Total Debt | 3.40B | 3.88B | 5.10B | 2.94B | 4.29B | 6.07B |
| Total Liabilities | 14.83B | 17.05B | 18.01B | 17.25B | 17.61B | 17.76B |
| Stockholders Equity | 60.43B | 60.65B | 55.46B | 53.84B | 49.10B | 44.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.55B | 3.09B | 5.28B | 5.31B | 6.24B |
| Operating Cash Flow | 0.00 | 9.08B | 7.88B | 9.89B | 9.87B | 10.59B |
| Investing Cash Flow | 0.00 | -6.19B | -4.63B | -5.09B | -5.04B | -4.62B |
| Financing Cash Flow | 0.00 | -5.12B | -3.24B | -4.56B | -4.55B | -3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥112.83B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
78 Outperform | ¥164.81B | 16.40 | ― | 3.39% | 14.21% | 29.38% | |
77 Outperform | ¥90.67B | 8.96 | ― | 3.82% | 3.68% | -46.19% | |
76 Outperform | ¥190.33B | 11.03 | ― | 2.50% | -2.46% | -10.72% | |
72 Outperform | ¥178.75B | 14.12 | 10.28% | 2.77% | 2.74% | 7.86% | |
67 Neutral | ¥91.95B | 17.07 | ― | 3.77% | -5.87% | 24.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |